Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer

Yang, LT; Jiang, XY; Yan, H; Li, YY; Zhen, HC; Chang, BM; Kariminia, S; Li, Q

Li, Q (reprint author), Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing 100050, Peoples R China.

BMC GASTROENTEROLOGY, 2018; 18 ():

Abstract

Background: For patients with advanced gastric cancer (AGC), second-line chemotherapy regimen remains controversial. The efficacy and safety of irinot......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索